BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18810196)

  • 1. Genesis and biology of vestibular schwannomas.
    Roche PH; Bouvier C; Chinot O; Figarella-Branger D
    Prog Neurol Surg; 2008; 21():24-31. PubMed ID: 18810196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on Tumor Biology in Vestibular Schwannoma.
    Nourbakhsh A; Dinh CT
    Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level.
    Neff BA; Welling DB; Akhmametyeva E; Chang LS
    Otol Neurotol; 2006 Feb; 27(2):197-208. PubMed ID: 16436990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.
    Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T
    Otol Neurotol; 2020 Jan; 41(1):e94-e102. PubMed ID: 31789805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis and molecular pathology of vestibular schwannoma].
    Brodhun M; Stahn V; Harder A
    HNO; 2017 May; 65(5):362-372. PubMed ID: 27421984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics.
    Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT
    J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA microarray analysis of vestibular schwannomas.
    Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
    Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
    Halum SL; Erbe CB; Friedland DR; Wackym PA
    Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
    Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
    Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
    Kimura Y; Saya H; Nakao M
    Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular biology and novel treatments of vestibular schwannomas.
    Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
    J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular studies of vestibular schwannomas: a review.
    Welling DB; Packer MD; Chang LS
    Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):341-6. PubMed ID: 17823551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.
    Dewan R; Pemov A; Kim HJ; Morgan KL; Vasquez RA; Chittiboina P; Wang X; Chandrasekharappa SC; Ray-Chaudhury A; Butman JA; Stewart DR; Asthagiri AR
    Neuro Oncol; 2015 Apr; 17(4):566-73. PubMed ID: 25452392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
    Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
    J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.